Jüngstes unrühmliches Beispiel , s.a. MiraGen (Kurs gestern/heute).
;-)
|
positive Phase3 Ganaxolone Studienergebnisse
endpts.com/...itive-phiii-readout-arrives-for-a-rare-disease/
1/4 Reverse Split
seekingalpha.com/news/3616107-marinus-reverse-split-shares-1-4
70 Mio. $ Offering
seekingalpha.com/news/...announces-pricing-of-equity-offering
Zahlen für 2020
www.sec.gov/Archives/edgar/data/1267813/...19095d1_ex99-1.htm
Verzögerung bei Phase-3-Studie RAISE Studie
ir.marinuspharma.com/news/news-details/...Trials/default.aspx
FDA Zulassung für ZTALMY/ganaxolone (in CDD)
"The FDA reviewed ZTALMY under Priority Review and granted ZTALMY orphan drug and Rare Pediatric Disease designations for the treatment of CDD. With the approval, the FDA awarded a Rare Pediatric Disease Priority Review Voucher (PRV), which Marinus plans to monetize."
ir.marinuspharma.com/news/news-details/...sorder/default.aspx
Im Tageshoch sogar über 12$.
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
2 | 40 | Marinus Pharmaceuticals Buy KZ 16 USD | Balu4u | Vassago | 17.11.22 14:01 | |
55 | ab Augusto Ticker MARINUS | buran | buran | 25.04.21 01:13 |